US09076W1099 - BIAF (XNAS)
bioAffinity Technologies, Inc. - Common Stock Acción
0,97 USD
Cotizaciones actuales de bioAffinity Technologies, Inc. - Common Stock
Bolsa | Ticker | Moneda | Última operación | Precio | Variación diaria | Variación diaria % |
---|---|---|---|---|---|---|
NASDAQ |
BIAF
|
USD
|
23.12.2024 19:13
|
0,97 USD
| 1,02 USD | -4,56 % |
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
-3,61 % | 5,82 % | -20,85 % | -49,03 % | -44,69 % | -35,95 % | -88,27 % |
Company Profile for bioAffinity Technologies, Inc. - Common Stock Share
bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.
Company Data for bioAffinity Technologies, Inc. - Common Stock Share
Name bioAffinity Technologies, Inc. - Common Stock
Company bioAffinity Technologies, Inc.
Symbol BIAF
Website https://www.bioaffinitytech.com
Primary Exchange
NASDAQ
ISIN US09076W1099
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Ms. Maria Zannes J.D.
Market Capitalization 28 Mio
Country United States of America
Currency USD
Employees 0,0 T
Address 22211 West Interstate 10, 78257 San Antonio
IPO Date 2022-09-01
Ticker Symbols
Name | Symbol |
---|---|
NASDAQ | BIAF |
More Shares
Investors who bioAffinity Technologies, Inc. - Common Stock hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.